Michael W. Kalb - Nov 4, 2022 Form 4 Insider Report for CinCor Pharma, Inc. (CINC)

Role
EVP & Chief Financial Officer
Signature
/s/ Cathy Rude, Attorney-in-Fact
Stock symbol
CINC
Transactions as of
Nov 4, 2022
Transactions value $
$0
Form type
4
Date filed
11/8/2022, 04:08 PM
Previous filing
Aug 2, 2022
Next filing
Jan 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CINC Common Stock Award $0 +25.4K $0.00 25.4K Nov 4, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CINC Employee Stock Option (Right to Buy) Award $0 +77.6K $0.00 77.6K Nov 4, 2022 Common Stock 77.6K $30.07 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's common stock. One-half (1/2) of the RSUs shall vest on November 4, 2024 and the remaining RSUs shall vest in two (2) equal annual installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.
F2 One-fourth (1/4th) of the shares subject to the option vest on November 4, 2023, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.